rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jonathan M. Cohen

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, 20/20 Biolabs.

Every Form 4 they filed

In numbers

Trades disclosed
2
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
3 Mar 2026
Last trade
3 Mar 2026
Last filed
4 Mar 2026

Companies traded

Where they are an officer
AIDX 20/20 BiolabsDirector, Officer, 10% owner · Professional Services · last 3 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Mar 2026filed 4 Mar 2026AIDX 20/20 Biolabsoption or derivative · Professional ServicesSEC FORM 4 Code A—352,936 at $0.00filing
3 Mar 2026filed 4 Mar 2026AIDX 20/20 Biolabsoption or derivative · Professional ServicesSEC FORM 4 Code A—352,936 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Alan B. BergmanChief Financial Officer · Chief Financial Officer at 20/20 Biolabs, filing Form 4 there in the last year
Jiming ZhouChief Operating Officer · Chief Operating Officer at 20/20 Biolabs, filing Form 4 there in the last year
Richard M. CohenDirector · Director at 20/20 Biolabs, filing Form 4 there in the last year
John G. ComptonDirector · Director at 20/20 Biolabs, filing Form 4 there in the last year
Michael A. RossDirector · Director at 20/20 Biolabs, filing Form 4 there in the last year